Study Title

Detection and Monitoring of Metastasis by 18F-DCFPyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer and Negative Conventional Imaging

Study Details

Description:

This study aimed to evaluate the diagnostic performance of 18F-DCFPyL (PyL) PET/CT in subjects presenting not previously treated for castration resistant prostate cancer and showing negative or equivocal findings per institutional standard of care conventional imaging

Sponsor:

CHU de Quebec-Universite Laval

Contacts:

Marjorie Besançon, PhD

marjorie.besancon@crchudequebec.ulaval.ca

418 525-4444 ext 20417

Marilyn Savard

marilyn.savard@crchudequebec.ulaval.ca

418 525-4444 ext 16848

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468